Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Cash Flow ⢠Rising Leverage ⢠Weakening Liquidity CHE delivers strong profitability and cash flow, but rising leverage, deteriorating liquidity, aggressive buybacks, and richer valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Downtrend persists ⢠Support test ⢠Reclaim $524 Support Level: $514â$515 Resistance Level: $520â$524 CHE is bearish over the last month, with support at $514â$515 and resistance at $520â$524; caution is warranted unless it reclaims $524.
Sentiment & News
Key News Insights: ⢠Fiduciary investigations ⢠Institutional buying ⢠Insider sale Chemed faces legal scrutiny and insider selling, though institutional buying and investor outreach provide a counterbalance.
AI Summary
CHE's strong VITAS-driven earnings and cash flow are now secondary to whether Medicare continuous-home-care billing withstands scrutiny; with modest valuation upside, weaker liquidity, and aggressive buybacks, investors should await clearer compliance resolution or evidence that VITAS margins remain durable under tighter oversight.
Description
Chemed Corporation delivers hospice and palliative care through a multidisciplinary network of clinicians, aides, social workers, clergy and volunteers across the United States under its VITAS segment, and provides plumbing, drain, excavation and water-restoration services to residential and commercial customers via company branches, independent contractors and franchisees under its Roto-Rooter segment. The company operates these two distinct businesses from its headquarters in Cincinnati and has been incorporated since 1970.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Apr 28 | May 5 | CHE | Chemed Corporation | Healthcare services beat-and-raise candidate: Q1 2026 revenue and adjusted EPS beat estimates, full-year guidance was raised, VITAS growth remained strong with admissions up 6.9%, and the company added a new $300M buyback authorization. | Closed | +1.5% |